Objective: Previous studies have reported an association between cyclooxygenase-2 (COX-2) polymorphism and gastric cancer (GC) susceptibility, but their results are controversial. This meta-analysis was intended to evaluate the relationship between the COX-2 rs20417 polymorphism and GC susceptibility in different ethnic groups.
Methods: We searched PubMed, EMBASE, Web of Knowledge, and the Chinese Biomedical Database (CBM) for relevant case-control studies published up to October 6, 2018, which reported an association between the COX-2 rs20417 polymorphism and gastric cancer risk. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of this association.
Results: 15 papers detailing case-control studies were included in the analysis, which included a total of 2848 GC cases and 4962 healthy controls. The meta-analysis results indicated that the COX-2 rs20417 polymorphism was associated with increased GC susceptibility under allele (G vs C: OR = 1.67, 95%CI = 1.19-2.35, P = .003), heterozygous (GG vs CG: OR = 1.44, 95%CI = 1.03-2.02, P = .034), dominant (GC+CC vs GG: OR = 1.66, 95%CI = 1.18-2.34, P = .004), homozygous (GG vs CC:OR = 2.20, 95%CI = 1.07-4.54, P = .033), and recessive models (CC vs GG+CG:OR = 2.05, 95%CI = 1.09-3.85, P = .025). An analysis of ethnic subgroups revealed that the COX-2 rs20417 polymorphism was significantly associated with GC susceptibility in Asians under all 5 models (G vs C: OR = 2.22, 95%CI = 1.66-2.96, P < .001; GG vs CC: OR = 4.29, 95%CI = 1.94-9.50, P < .001; GG vs CG: OR = 1.86, 95%CI = 1.34-2.58, P < .001; CC vs GG+CG: OR = 3.73, 95%CI = 1.92-7.24, P < .001; GC+CC vs GG: OR = 2.20, 95%CI = 1.65-2.93, P < .001). Helicobacter pylori positive patients suffered a high risk of GC, compared to H pylori negative patients under the dominant model (OR = 3.09, 95%CI = 1.80-5.32, P < .001).
Conclusion: This meta-analysis of 15 case-control studies provides strong evidence that the COX-2 rs20417 polymorphism increases the risk of GC susceptibility in general populations, especially in Asians. Helicobacter pylori positive patients and those with the COX-2 rs20417 polymorphism had a higher risk of developing GC.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504336 | PMC |
| http://dx.doi.org/10.1097/MD.0000000000015468 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The associations of candidate gene polymorphisms with aspirin resistance in patients with ischemic disease: a meta-analysis.
Hum Genomics
December 2024
Department of Pharmacy, Peking University Third Hospital, No. 49 North Garden Road, Haidian District, Beijing, China.
Article Synopsis
- Recent studies have focused on the link between genetic variations (polymorphisms) and aspirin resistance (AR) in patients with ischemic diseases, aiming to identify potential biomarkers for genetic testing before prescribing aspirin.
- The research involved analyzing 75 articles and evaluating 94 candidate gene polymorphisms, with 25 genes undergoing meta-analysis, revealing 23 significant associations with AR, including notable genes like PTGS2 and ITGA2.
- Subgroup analyses further highlighted specific genetic variations associated with AR across different populations, emphasizing the need for tailored approaches in aspirin therapy based on genetic profiles.
Genetic factors related to aspirin resistance using the Multiplate® device in Hong Kong Chinese patients with stable coronary heart disease.
Heliyon
July 2024
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Article Synopsis
- The study aimed to explore the link between specific genetic variations (SNPs) and aspirin resistance (AR) in patients using long-term aspirin therapy to understand individual responses to the medication.
- It involved 266 patients with stable coronary heart disease who took low-dose aspirin and had their blood samples analyzed to measure aspirin's effectiveness by checking thromboxane B2 levels and platelet function.
- The findings indicated that two specific SNPs were significantly associated with reduced effects of aspirin on platelet aggregation, suggesting a genetic influence on AR, though further research is needed to confirm these results.
Genetic variations in immune mediators and prostate cancer risk: A field synopsis with Bayesian calculations.
Cytokine
July 2024
Post Graduation Program in Basic and Applied Immunology, Federal University of Amazonas, Manaus, Amazonas, Brazil.
Article Synopsis
- The study aimed to reevaluate data from existing meta-analyses on genetic variations in immune mediators and their link to prostate cancer risk using Bayesian methods.
- Researchers reviewed literature on immune mediator gene polymorphisms before September 2023, applying two Bayesian approaches to assess significance, while also evaluating study quality using the Venice criteria.
- Findings revealed that polymorphisms rs1143627 in IL1B and rs1946518 in IL18 were identified as significant biomarkers for prostate cancer risk, with only four studies meeting the highest evidence criteria.
The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations.
Cancer Chemother Pharmacol
May 2024
Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Life Sciences, Northwest University, #229 North TaiBai Road, Xi'an, 710069, Shaanxi, China.
Article Synopsis
- Pharmacogenomics studies how genetic differences influence drug metabolism and reactions, aiming to understand these variations in the Jingpo population.
- The research used the Agena MassARRAY Assay to analyze 57 genetic variants in 159 Jingpo individuals, comparing their data to 26 other populations.
- Key findings included identifying six significant genetic loci associated with drug metabolism and toxicity, which could impact treatment efficacy and safety for Jingpo individuals.
Genetic polymorphisms of pharmacogenomic VIP variants in the Hui population from Ningxia Province of China.
Funct Integr Genomics
March 2023
Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Life Sciences, Northwest University, Xi'an, 710069, Shaanxi, China.
Article Synopsis
- - The research focuses on the pharmacogenomics of the Hui population, identifying significant genetic variants that affect drug metabolism and treatment effectiveness.
- - A total of 53 VIP variants across 26 genes were genotyped in 200 Hui individuals, revealing notable differences in genetic frequencies when compared to 26 other populations.
- - Key variants, such as those in PTGS2, NAT2, ACE, and CYP2D6, were found to potentially impact responses to various medications, providing a basis for personalized treatments in the Hui population.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!